[Search]
[by date] [by subject] [by continent]

Clinical Infection Control in Gene Therapy: A Multidisciplinary Conference

University of Kentucky Chandler Medical Center , Marriott's Griffin Gate Resort, Lexington, Kentucky
October 22-23, 1999

Invited Speakers: Stephen M. W. Chang, PhD
Carol Conrad, MD
Stephen L. Eck, MD, PhD
Martin E. Evans, MD
Julie L. Gerberding, MD, MPH
Craig T. Jordan, PhD
Howard L. Kaufman, MD
C. Glen Mayhall, MD
Jan A. Nolta, PhD
Anne M. Pilaro, PhD
Sean Sullivan, PhD
David J. Weber, MD, MPH, MHA
Nelson A. Wivel, MD

Program:
Friday, October 22, 1999
7:15 AM - 7:45 AM Registration/Continental Breakfast
7:45 AM - 8:00 AM Welcome and Announcements
Martin E. Evans, MD
Session I - Gene Therapy and Regulatory Matters
Martin E. Evans, MD, Moderator
8:00 AM - 8:20 AM A general overview of the numbers and types of protocols submitted to the NIH Recombinant DNA Advisory Committee, including perspectives on safety, infection control, and the future of clinical gene therapy
Nelson A. Wivel, MD
8:20 AM - 8:40 AM An overview of the role the FDA has in reviewing and approving gene therapy protocols for use in the clinical setting with an emphasis on safety and infection control considerations - Anne M. Pilaro, PhD
Session II - Virology and Clinical Applications
Craig T. Jordan, PhD, Moderator
8:40 AM - 9:10 AM General overview of gene therapy with an emphasis on clinical applications including past and current experience with infection control issues
Stephen L. Eck, MD, PhD
9:10 AM - 9:40 AM Retroviruses (including lentiviruses)*
Jan Nolta, PhD
9:40 AM - 10:10 AM Adenoviruses*
Stephen M. W. Chang, PhD
10:10 AM - 10:40 AM Adeno-associated Viruses*
Carol Conrad, MD
10:40 AM - 11:00 AM Coffee Break
11:00 AM - 11:30 AM Poxviruses*
Howard L. Kaufman, MD
11:30 AM - Noon Non-Infectious Vectors*
Sean Sullivan, PhD
*Format
Virology including disease caused by wild-type virus
Recombinational strategies
Clinical applications of the vectors and the results of studies
Infection control implications
12:15 PM - 1:30 PM Lunch at Marriott’s Griffin Gate Resort
1:30 PM - 1:45 PM Introductory Remarks/Announcements
Martin E. Evans, MD
Session III - Infection Control Considerations
Martin E. Evans, MD, Moderator
1:45 PM - 2:15 PM Experience and perspectives from the Hospital Infections Program, Centers for Disease Control and Prevention. Delineation of infection control topics to be ad- dressed in the focus sessions. - Julie L. Gerberding, MD, MPH
2:15 PM - 2:45 PM Review of experience with infection control in gene therapy at the University of North Carolina at Chapel Hill.
David Weber, MD, MPH, MHA
2:45 PM - 3:00 PM Coffee Break
3:00 PM - 5:00 PM Infection Control in Gene Therapy
Breakout Focus Sessions
Format- Discuss scientific information relevant to infection control of the vector and issues surrounding infection control for the vector.
u Retroviruses - C. Glen Mayhall, MD, and Jan Nolta, PhD
u Adenoviruses - David Weber, MD, MPH, MHA and
Stephen M. W. Chang, PhD
u Adeno-associated viruses - Martin E. Evans, MD, and
Carol Conrad, MD
u Poxviruses - Julie L. Gerberding, MD, MPH, and
Howard L. Kaufman, MD
7:00 PM - 9:00 PM Informal Reception and Dinner at
Marriott’s Griffin Gate Resort

Saturday, October 23, 1999
7:15 AM - 7:45 AM Registration/Continental Breakfast
7:45 AM - 8:00 AM Introductory Remarks/Announcements
Martin E. Evans, MD
Session IV - Recommendations for Infection Control in Gene Therapy
Martin E. Evans, MD, Moderator
Focus Session Reports
8:00 AM - 8:20 AM Retroviruses - C. Glen Mayhall, MD
8:20 AM - 8:40 AM Adenoviruses
David Weber, MD, MPH, MHA
8:40 AM - 9:00 AM Adeno-associated Viruses
Martin E. Evans, MD
9:00 AM - 9:20 AM Poxviruses - Julie L. Gerberding, MD, MPH
9:20 AM - 9:50 AM Coffee Break
9:50 AM - 11:00 AM Roundtable Discussion
All conference participants
Focus session reports
Regulatory items (roles of FDA, RAC, IRB, IBC, etc.)
Environmental Health & Safety issues
Where to from here?
11:00 AM - 11:30 AM Overview and Summary of the Meeting
Martin E. Evans, MD
Noon - 5:00 PM Lunch and Horse Races at Keeneland Race Course
On Your Own - Transportation Provided

Registration :
The $150 registration fee includes course materials as well as continental
breakfasts both days, lunch and dinner on Friday, and bus transportation to
Keeneland Race Course on Saturday. Enrollment is limited, and advance
registration is required. Please return your completed registration form
and payment no later than October 15. After the deadline, registrations will
be accepted on a space available basis. Substitutions may be made if
necessary.
Contact: Ellen VanHoose
Allied Health Continuing Education
University of Kentucky
301 East Main Street Suite 400
Lexington KY 40507-1507
Phone: (606) 257-5320 ext. 224
FAX: (606) 323-2920






Deadline for Abstracts: 10/15/99

Email for Requests and Registration: ellenv@pop.uky.edu


Posted by: J. Ellen VanHoose Host: 128.163.35.54 date: September 07, 1999 13:27:45
Generated by meetings and positions 1.0 by Kai Garlipp